Table 1

Demographic characteristics of VaD patients in tertiary hospitals in China, 2016–2018

VariablesTotal
(n=123 700)
2016
(n=46 464)
2017
(n=45 317)
2018
(n=51 009)
Age, mean±SD74.13±10.8873.93±10.9875.10±10.5974.73±10.81
Male, n (%)75 406 (61.0)28 422 (61.2)28 224 (62.3)31 386 (61.5)
Occupation, n (%)
 Retired49 045 (39.6)18 445 (39.7)19 542 (43.1)21 743 (42.6)
 Employed41 362 (33.4)14 477 (31.2)15 316 (33.80)17 555 (34.4)
 Agricultural worker25 258 (20.4)10 707 (23.0)7422 (16.4)8644 (16.9)
 Unemployed8035 (6.5)2835 (6.1)3037 (6.7)3067 (6.0)
Access to hospitals, n (%)
Emergency27 825 (22.5)8866 (19.1)10 176 (22.5)11 916 (23.4)
Outpatient75 977 (61.4)26 793 (57.7)29 338 (64.7)33 501 (65.7)
Other19 898 (16.1)10 805 (23.3)5803 (12.8)5592 (11.0)
Hospital burden
Number of hospitalisations, mean±SD2.96±0.173.04±0.223.47±0.233.63±0.23
Number of patients with ≥2 hospital records, n (%)44 755 (36.2)15 848 (34.1)17 856 (39.4)21 404 (42.0)
Length of stay, median (IQR), days (quartile 1–quartile 2)11.00 (8.00–17.00)12.00 (8.00–18.00)12.00 (8.00–18.00)11.00 (8.00–17.00)
Hospitalisation cost, median (IQR), CYN (¥) (quartile 1–quartile 2)10 807.92 (6838.84–18 535.30)10 926.09 (6930.71–19 256.49)11 407.88 (7157.49–19 785.61)11 123.75 (6933.98–19 316.48)
Hospitalisation cost self-funded, median (IQR), CYN (¥) (quartile 1–quartile 2)3947.32 (1806.86–8774.79)4377.51 (1932.24–9162.54)3713.49 (1717.15–8854.89)3592.56 (1624.15–8373.61)
Payment methods, n (%)
UEBMI55 984 (45.3)21 800 (46.9)23 353 (51.5)26 207 (51.4)
URBMI19 197 (15.5)5091 (11.0)6602 (14.6)9434 (18.5)
NRCMI13 454 (10.9)4892 (10.5)4946 (10.9)4670 (9.2)
CHI382 (0.3)145 (0.3)148 (0.3)147 (0.3)
Fully self-funded11 436 (9.2)4234 (9.1)4581 (10.1)4435 (8.7)
Other23 247 (18.8)10 302 (22.2)5687 (12.5)6116 (12.0)
Comorbidities, n (%)
Hypertension83 070 (67.2)30 578 (65.8)31 160 (68.8)35 179 (69.0)
Heart disease (chronic ischaemic heart disease, heart failure and arrhythmia)78 724 (63.6)27 215 (58.6)30 503 (67.3)32 278 (63.3)
Cerebral infarction68 691 (55.5)23 333 (50.2)25 654 (56.6)29 761 (58.3)
Diabetes52 479 (42.4)17 725 (38.1)20 582 (45.4)23 444 (46.0)
Cerebral vascular disease sequelae38 110 (30.8)13 361 (28.8)15 246 (33.6)17 648 (34.6)
Metabolic abnormalities (disorders of fluid-electrolyte and acid–base balance, other amino acid metabolism disorders)33 037 (26.7)10 557 (22.7)12 180 (26.9)13 990 (27.4)
Atherosclerosis23 365 (18.9)6967 (15.0)8666 (19.1)11 220 (22.0)
Hyperlipidaemia16 157 (13.1)5798 (12.5)5878 (13.0)6659 (13.1)
Respiratory diseases (chronic obstructive pulmonary disease) and other respiratory disorders19 191 (15.5)9985 (21.5)7191 (15.9)7948 (15.6)
Benign prostatic hyperplasia15 267 (12.3)5760 (12.4)6301 (13.9)7058 (13.8)
Other cerebral vascular disease16 472 (13.3)5364 (11.5)6220 (13.7)7346 (14.4)
  • CHI, Commercial Health Insurance; NRCMI, The New Rural Cooperative Medical Insurance; UEBMI, The Urban Employee Basic Medical Insurance; URBMI, The Urban Resident Basic Medical Insurance; VaD, vascular dementia.